Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

VYNE – vyne therapeutics inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VYNE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
04:09 pm
vyne
Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: CITADEL ADVISORS LLC
Low Report
Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: CITADEL ADVISORS LLC
Report
11/14
03:23 pm
vyne
Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Low Report
Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Report
11/14
01:10 pm
vyne
Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: Cormorant Asset Management, LP
Low Report
Form SCHEDULE 13G/A VYNE Therapeutics Inc. Filed by: Cormorant Asset Management, LP
Report
11/12
04:13 pm
vyne
Form ARS VYNE Therapeutics Inc. For: Dec 31
Low Report
Form ARS VYNE Therapeutics Inc. For: Dec 31
Report
11/12
04:09 pm
vyne
Form DEF 14A VYNE Therapeutics Inc. For: Dec 12
Low Report
Form DEF 14A VYNE Therapeutics Inc. For: Dec 12
Report
11/6
04:01 pm
vyne
Form 10-Q VYNE Therapeutics Inc. For: Sep 30
High Report
Form 10-Q VYNE Therapeutics Inc. For: Sep 30
Report
11/6
08:02 am
vyne
Form 8-K VYNE Therapeutics Inc. For: Nov 06
Medium Report
Form 8-K VYNE Therapeutics Inc. For: Nov 06
Report
10/2
05:05 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Harsch Mutya
High Report
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Harsch Mutya
Report
10/2
05:05 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Stuart Iain
High Report
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Stuart Iain
Report
10/2
05:05 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Domzalski David
High Report
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Domzalski David
Report
10/2
05:05 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Zeronda Tyler
High Report
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Zeronda Tyler
Report
9/12
04:03 pm
vyne
Form 8-K VYNE Therapeutics Inc. For: Sep 11
Low Report
Form 8-K VYNE Therapeutics Inc. For: Sep 11
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0